Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• AT-rich interactive domain-containing protein 1A (ARID1A) is a known tumor suppressor in various cancers.
• The specific role of ARID1A in osteosarcoma pathogenesis remains largely uncharacterized.

Purpose of the Study:

• To investigate the expression patterns of ARID1A in human osteosarcoma.
• To determine the prognostic significance of ARID1A in osteosarcoma patients.
• To elucidate the biological functions of ARID1A in osteosarcoma cell proliferation, apoptosis, and metastasis.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) was used to examine ARID1A mRNA expression in 53 osteosarcoma specimens and matched adjacent non-tumour tissues.
• ARID1A expression levels were correlated with clinical parameters, including tumor stage and distant metastasis.
• In vitro experiments involved restoring ARID1A expression in osteosarcoma cell lines (MG-63, U2OS) to assess its impact on cell proliferation and metastasis.

Main Results:

• ARID1A mRNA expression was significantly downregulated in osteosarcoma tissues compared to adjacent non-tumour tissues.
• Lower ARID1A expression was inversely correlated with advanced tumor stage, presence of distant metastasis, and poorer overall survival in osteosarcoma patients.
• ARID1A downregulation was observed in four human osteosarcoma cell lines (MG-63, U2OS, HOS, Saos-2).
• Restoration of ARID1A expression in MG-63 and U2OS cells significantly inhibited cell proliferation and metastasis in vitro.

Conclusions:

• ARID1A functions as a tumor suppressor in osteosarcoma progression.
• ARID1A expression levels serve as a valuable prognostic marker for osteosarcoma.
• ARID1A represents a potential therapeutic target for osteosarcoma treatment.